Progression-directed ablative radiotherapy improves event-free survival in oligoprogressive NSCLC

IntroductionTo assess the efficacy of progression-directed radiation therapy (PDRT) in patients with oligoprogressive non-small cell lung cancer (NSCLC), with particular focus on disease progression and changes in systemic therapy.Materials and methodsFrom January 2020 to October 2025, a retrospecti...

Cijeli opis

Bibliografski detalji

Glavni autori:	Lorenzo De Sanctis, Riccardo Ray Colciago, Giulia Rossano, Matteo Ferrari, Matteo Mombelli, Ilenia Manno, Federica Ferrario, Sara Saufi, Valeria Faccenda, Denis Panizza, Gaia Passarella, Stefania Canova, Diego Luigi Cortinovis, Stefano Arcangeli
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2026-05-01
Serija:	Frontiers in Oncology
Teme:	event-free survival local control oligoprogressive non-small cell lung cancer progression-directed radiation therapy systemic therapy
Online pristup:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1766544/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!